News

Eli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?
Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...
What to Know About Eli Lilly’s Daily Pill for Weight Loss
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
Weight loss in a pill? Eli Lilly just took a big step closer to making it happen.
Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...
Eli Lilly finds its weight-loss pill works just as well as Ozempic — and investors are loving it
Eli Lilly shares are now positive for the year, up 10% since the start of January.
Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Forbes5d
Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily weight loss pill, orforglipron, demonstrated effectiveness consistent with ...
Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...